No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients.

Abstract

Patients treated with BRAF inhibitors (e.g. vemurafenib), a novel targeted therapy for advanced melanoma harbouring certain BRAF mutations, develop numerous adverse cutaneous side effects, including skin tumors such as squamous cell carcinoma or non-malignant verruciform keratinocyte proliferations, termed 'BRAF-inhibitor-associated verrucous keratosis… (More)
DOI: 10.1111/exd.12249

Topics

4 Figures and Tables

Cite this paper

@article{Ganzenmueller2013NoHV, title={No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients.}, author={Tina Ganzenmueller and Elias Hage and Yuri Yakushko and Jeanette Kluba and Sabrina Woltemate and Vivien Schacht and Thomas F Schulz and Ralf Gutzmer}, journal={Experimental dermatology}, year={2013}, volume={22 11}, pages={725-9} }